Cargando…
Expression and characterization of a soluble VEGF receptor 2 protein
OBJECTIVE: To clone and express a truncated, soluble vascular endothelial growth factor receptor 2 (sVEGFR2) possessing the combined-functional domains 1–3 and 5 in eukaryotic cells and to test the inhibitory effects of full length VEGFR2 in vivo. RESULTS: pCMV6-trunctated-rVegfr2 (6100 bp) was succ...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977943/ https://www.ncbi.nlm.nih.gov/pubmed/24618407 http://dx.doi.org/10.1186/2045-3701-4-14 |
_version_ | 1782310482208620544 |
---|---|
author | Liu, Wei Zhang, Xinyuan Song, Ching Bao, Shisan Lai, Donna Mou, Jianqiu Jiang, Tao Wang, Ningli |
author_facet | Liu, Wei Zhang, Xinyuan Song, Ching Bao, Shisan Lai, Donna Mou, Jianqiu Jiang, Tao Wang, Ningli |
author_sort | Liu, Wei |
collection | PubMed |
description | OBJECTIVE: To clone and express a truncated, soluble vascular endothelial growth factor receptor 2 (sVEGFR2) possessing the combined-functional domains 1–3 and 5 in eukaryotic cells and to test the inhibitory effects of full length VEGFR2 in vivo. RESULTS: pCMV6-trunctated-rVegfr2 (6100 bp) was successfully cloned. The transfection experiments showed that either pCMV6-truncated-rat-Vegfr2 (pCMV6-truncated-rVegfr2) or pCMV6-rVegfr2 inhibited the expression of intracellular green fluorescent protein, which is usually used as an exogenous transfected reporter gene to determine the transfected efficiency. An analysis of the transfected cells revealed that the amount of full-length VEGFR2 protein in the pCMV6-truncated-rVegfr2 transfected cells was 20% lower than that in the negative control (non-transfected HEK 293 cells). The differences in test results between the transfected and negative control groups were greatest from 24–30 h after transfection; this period was therefore chosen as optimal for collecting culture supernatants. This analysis was highly sensitive for detecting the amount of sVEGFR2 protein expressed and secreted by the cells, and the sVEGFR2 protein content was found to increase by approximately 26% in the transfected cells compared to that in the negative control cells (68.2% ± 1.7% vs. 41.9% ± 2.9%, P = 0.000) and by 18% compared to the negative control cells (68.2% ± 1.7% vs. 50.0% ± 0.5%, P = 0.003). Propidium iodide and Hoechst staining indicated no significant change in the number of HEK293 cells undergoing apoptosis 6 days after pCMV6-trucated-Vegfr2 transfection, compared to the negative control. Soluble VEGFR2 produced by pCMV6-truncated-rVegfr2 inhibited full-length VEGFR2 protein expression in the cell membrane. CONCLUSIONS: This study employed a eukaryotic system to express sVEGFR2. The use of transient transfection technology greatly improved transfect efficiency. Recombinant sVEGFR2 inhibited the effect of endogenous full-length VEGFR2 but was not cytotoxic. |
format | Online Article Text |
id | pubmed-3977943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39779432014-04-21 Expression and characterization of a soluble VEGF receptor 2 protein Liu, Wei Zhang, Xinyuan Song, Ching Bao, Shisan Lai, Donna Mou, Jianqiu Jiang, Tao Wang, Ningli Cell Biosci Research OBJECTIVE: To clone and express a truncated, soluble vascular endothelial growth factor receptor 2 (sVEGFR2) possessing the combined-functional domains 1–3 and 5 in eukaryotic cells and to test the inhibitory effects of full length VEGFR2 in vivo. RESULTS: pCMV6-trunctated-rVegfr2 (6100 bp) was successfully cloned. The transfection experiments showed that either pCMV6-truncated-rat-Vegfr2 (pCMV6-truncated-rVegfr2) or pCMV6-rVegfr2 inhibited the expression of intracellular green fluorescent protein, which is usually used as an exogenous transfected reporter gene to determine the transfected efficiency. An analysis of the transfected cells revealed that the amount of full-length VEGFR2 protein in the pCMV6-truncated-rVegfr2 transfected cells was 20% lower than that in the negative control (non-transfected HEK 293 cells). The differences in test results between the transfected and negative control groups were greatest from 24–30 h after transfection; this period was therefore chosen as optimal for collecting culture supernatants. This analysis was highly sensitive for detecting the amount of sVEGFR2 protein expressed and secreted by the cells, and the sVEGFR2 protein content was found to increase by approximately 26% in the transfected cells compared to that in the negative control cells (68.2% ± 1.7% vs. 41.9% ± 2.9%, P = 0.000) and by 18% compared to the negative control cells (68.2% ± 1.7% vs. 50.0% ± 0.5%, P = 0.003). Propidium iodide and Hoechst staining indicated no significant change in the number of HEK293 cells undergoing apoptosis 6 days after pCMV6-trucated-Vegfr2 transfection, compared to the negative control. Soluble VEGFR2 produced by pCMV6-truncated-rVegfr2 inhibited full-length VEGFR2 protein expression in the cell membrane. CONCLUSIONS: This study employed a eukaryotic system to express sVEGFR2. The use of transient transfection technology greatly improved transfect efficiency. Recombinant sVEGFR2 inhibited the effect of endogenous full-length VEGFR2 but was not cytotoxic. BioMed Central 2014-03-11 /pmc/articles/PMC3977943/ /pubmed/24618407 http://dx.doi.org/10.1186/2045-3701-4-14 Text en Copyright © 2014 Liu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Liu, Wei Zhang, Xinyuan Song, Ching Bao, Shisan Lai, Donna Mou, Jianqiu Jiang, Tao Wang, Ningli Expression and characterization of a soluble VEGF receptor 2 protein |
title | Expression and characterization of a soluble VEGF receptor 2 protein |
title_full | Expression and characterization of a soluble VEGF receptor 2 protein |
title_fullStr | Expression and characterization of a soluble VEGF receptor 2 protein |
title_full_unstemmed | Expression and characterization of a soluble VEGF receptor 2 protein |
title_short | Expression and characterization of a soluble VEGF receptor 2 protein |
title_sort | expression and characterization of a soluble vegf receptor 2 protein |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977943/ https://www.ncbi.nlm.nih.gov/pubmed/24618407 http://dx.doi.org/10.1186/2045-3701-4-14 |
work_keys_str_mv | AT liuwei expressionandcharacterizationofasolublevegfreceptor2protein AT zhangxinyuan expressionandcharacterizationofasolublevegfreceptor2protein AT songching expressionandcharacterizationofasolublevegfreceptor2protein AT baoshisan expressionandcharacterizationofasolublevegfreceptor2protein AT laidonna expressionandcharacterizationofasolublevegfreceptor2protein AT moujianqiu expressionandcharacterizationofasolublevegfreceptor2protein AT jiangtao expressionandcharacterizationofasolublevegfreceptor2protein AT wangningli expressionandcharacterizationofasolublevegfreceptor2protein |